Page last updated: 2024-10-18

glycine and Hemangioma, Cavernous, Central Nervous System

glycine has been researched along with Hemangioma, Cavernous, Central Nervous System in 1 studies

Hemangioma, Cavernous, Central Nervous System: A vascular anomaly composed of a collection of large, thin walled tortuous VEINS that can occur in any part of the central nervous system but lack intervening nervous tissue. Familial occurrence is common and has been associated with a number of genes mapped to 7q, 7p and 3q. Clinical features include SEIZURES; HEADACHE; STROKE; and progressive neurological deficit.

Research Excerpts

ExcerptRelevanceReference
"Familial cerebral cavernous malformation (CCM) exhibits autosomal dominant inheritance and is characterized by vascular disorders of the brain, which can lead to seizures, focal neurological deficits, hemorrhagic stroke, and migraine."1.32Identification of a novel KRIT1 mutation in an Italian family with cerebral cavernous malformation by the protein truncation test. ( Dorcaratto, A; Ferrera, L; Garrè, C; Mareni, C; Marini, V; Origone, P; Viale, G, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marini, V1
Ferrera, L1
Dorcaratto, A1
Viale, G1
Origone, P1
Mareni, C1
Garrè, C1

Other Studies

1 other study available for glycine and Hemangioma, Cavernous, Central Nervous System

ArticleYear
Identification of a novel KRIT1 mutation in an Italian family with cerebral cavernous malformation by the protein truncation test.
    Journal of the neurological sciences, 2003, Aug-15, Volume: 212, Issue:1-2

    Topics: Cysteine; DNA Mutational Analysis; Genetic Linkage; Glycine; Hemangioma, Cavernous, Central Nervous

2003